This post is published on http://patentcircle.blogspot.com/2008/09/cipla-mocks-roches-patent-for.html.
Mumbai-generic major Cipla has yet again made a mockery of Indian patent law by launching a generic version of Roche patented anti-infection drug Valganciclovir. This is the second instance of Cipla mocking Indian patent after it deliberately launched generic copy of Roche patented anti-cancer drug Erlotinib. Though we are not sure how much impact this will make on availability of drugs to Indian patients but surely it will deteriorate India’s image in global IP scenario. What is more...
I invite comments on this post for further discussion.
Related links: http://www.business-standard.com/india/storypage.php?autono=335321
http://spicyipindia.blogspot.com/2008/09/cipla-takes-on-roche-again-valcyte-vs.html
No comments:
Post a Comment